Related references
Note: Only part of the references are listed.Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer
E. L. Korn et al.
ANNALS OF ONCOLOGY (2016)
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis
J. Beardsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
Scott R. Evans et al.
CLINICAL INFECTIOUS DISEASES (2015)
The Strength of Association Between Surrogate End Points and Survival in Oncology A Systematic Review of Trial-Level Meta-analyses
Vinay Prasad et al.
JAMA INTERNAL MEDICINE (2015)
Ditch the term pathogen
Arturo Casadevall et al.
NATURE (2014)
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
Gregory P. Bisson et al.
CLINICAL INFECTIOUS DISEASES (2013)
Combination Antifungal Therapy for Cryptococcal Meningitis REPLY
Jeremy N. Day et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Combination Antifungal Therapy for Cryptococcal Meningitis
Jeremy N. Day et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Epidemiology of Cryptococcal Meningitis in the US: 1997-2009
Vasilios Pyrgos et al.
PLOS ONE (2013)
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis
Arthur T. Jackson et al.
AIDS (2012)
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial
Joseph N. Jarvis et al.
AIDS (2012)
Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis
Angela Loyse et al.
CLINICAL INFECTIOUS DISEASES (2012)
Biomarkers and surrogate endpoints in clinical trials
Thomas R. Fleming et al.
STATISTICS IN MEDICINE (2012)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS-Associated Acute Cryptococcal Meningitis: A Randomized, Double-Blind Clinical Trial of Efficacy and Safety
Richard J. Hamill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Combination Flucytosine and High-Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi
Jesse C. Nussbaum et al.
CLINICAL INFECTIOUS DISEASES (2010)
Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub-Saharan Africa
Azure T. Makadzange et al.
CLINICAL INFECTIOUS DISEASES (2010)
Liposomal amphotericin B (Fungisome TM ) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: A multicentric, randomized controlled trial
M. P. Jadhav et al.
JOURNAL OF POSTGRADUATE MEDICINE (2010)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV-Associated Cryptococcal Meningitis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV-Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: A randomized trial
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2008)
Individual- and trial-level surrogacy in colorectal cancer
Marc Buyse et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints
Marissa N. Lassere
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: A randomized controlled trial
Malee Techapornroong et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Recombinant interferon-γ1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis
PG Pappas et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
AE Brouwer et al.
LANCET (2004)
Small-sample adjustments for Wald-type tests using sandwich estimators
MP Fay et al.
BIOMETRICS (2001)
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter
S Kim et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2000)
Share Paper
